South America Biobanks Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)


No. of Pages: 159    |    Report Code: TIPRE00027971    |    Category: Life Sciences

South America Biobanks Market
Buy Now

The biobanks market in South America is expected to grow from US$ 190.08 million in 2021 to US$ 261.23 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2021 to 2028.

Regenerative therapies help induce the regeneration of cells, tissues, and organs and restore their functions. Rapid advancements in regenerative medicines to provide effective solutions for chronic conditions drive market growth. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in developing regenerative medicine technologies and has a huge pipeline of products for various conditions, such as diabetes, Hemophilia A, and hyperthyroidism. Biobank is a major asset in the field of regenerative medicine as it provides materials for research, development, and therapy. Furthermore, associating each biospecimen (in part or in whole) with relevant patient demographics and medical data can be a source of big data that leads to improved patient outcomes and new therapeutic approaches developments. As the foundation for a successful regenerative medicine and tissue engineering program, investing in biobanking can yield considerable cost recoveries. Thus, the rising adoption of regenerative medicines propels the growth of the biobanks market.

 

The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. Market players and Sample losses their business due to the temporarily shutting down of enterprises in various regions. In this situation, pediatric imaging and other associated treatment is stopped. Biobanks are critical for speeding up research. The COVID19 collection and characterization were began by the Argentinean Biobank of Infectious Diseases (BBEI) early in the SARS-CoV-2 epidemic. Biobanks are critical components in the advancement of fundamental, preclinical, translational, and clinical research. As SARS-CoV-2 expanded over the world, there was, and continues to be, a pressing need to learn more about the virus, to comprehend and treat the wide range of clinical manifestations it causes, and to halt its transmission in humans. As a result, the scientific community's demand for samples from infected or recovered individuals, as well as the clinical data that goes with them, has increased dramatically. Latin America confronts the issue of addressing genetic variability in research to improve pharmacological responses to medicines for diseases due to its vast population diversity. The establishment of biobanks, as well as their strengthening and collaboration, would be critical in obtaining pharmacogenetic information and effective therapeutic responses in South America.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America biobanks market. The South America biobanks market is expected to grow at a good CAGR during the forecast period.

 

South America Biobanks market Revenue and Forecast to 2028 (US$ Million)

 
South America Biobanks market Revenue and Forecast to 2028 (US$ Million)   

South America Biobanks Market Segmentation

South America Biobanks Market – By

Product and Service

  • Equipment

    • Storage Equipment
    • Sample Analysis Equipment
    • Sample Processing Equipment
    • Sample Transport Equipment
  • Consumables

    • Storage Consumables
    • Analysis Consumables
    • Processing Consumables
    • Collection Consumables
  • Service

    • Storage Services
    • Processing Services
    • Transport Services
    • Supply Services
  • Software

South America Biobanks Market – By

Sample

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Others

South America Biobanks Market – By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

South America Biobanks Market – By

Country

  • Brazil
  • Argentina
  • Rest of SAM

South America Biobanks Market – Companies Mentioned

  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • SciSafe Inc.     

South America Biobanks Strategic Insights

Strategic insights for the South America Biobanks provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-america-biobanks-market-strategic-framework.webp
Get more information on this report

South America Biobanks Report Scope

Report Attribute Details
Market size in 2021 US$ 190.08 Million
Market Size by 2028 US$ 261.23 Million
Global CAGR (2021 - 2028) 4.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product and Service
  • Equipment
  • Consumables
  • Service
  • Software
By Sample
  • Blood Products
  • Human Tissues
  • Cell Lines
By Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • Get more information on this report

    South America Biobanks Regional Insights

    The geographic scope of the South America Biobanks refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-america-biobanks-market-geography.webp
    Get more information on this report

    The List of Companies - South America Biobanks Market

    1. THERMO FISHER SCIENTIFIC INC.
    2. Tecan Trading AG
    3. QIAGEN
    4. Hamilton Company
    5. Avantor, Inc.
    6. MICRONICS JAPAN CO., LTD.
    7. BD
    8. Taylor-Wharton
    9. Brooks Automation, Inc.
    10. Promega Corporation
    11. SciSafe Inc.
    Frequently Asked Questions
    How big is the South America Biobanks Market?

    The South America Biobanks Market is valued at US$ 190.08 Million in 2021, it is projected to reach US$ 261.23 Million by 2028.

    What is the CAGR for South America Biobanks Market by (2021 - 2028)?

    As per our report South America Biobanks Market, the market size is valued at US$ 190.08 Million in 2021, projecting it to reach US$ 261.23 Million by 2028. This translates to a CAGR of approximately 4.6% during the forecast period.

    What segments are covered in this report?

    The South America Biobanks Market report typically cover these key segments-

    • Product and Service (Equipment, Consumables, Service, Software)
    • Sample (Blood Products, Human Tissues, Cell Lines)
    • Application (Regenerative Medicine, Life Science Research, Clinical Research)

    What is the historic period, base year, and forecast period taken for South America Biobanks Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Biobanks Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South America Biobanks Market?

    The South America Biobanks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • SciSafe Inc.
  • Who should buy this report?

    The South America Biobanks Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Biobanks Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now